B52 Plasmodium malariae malaria

Name of the Condition

• Plasmodium malariae malaria

Summary

Plasmodium malariae malaria is a parasitic infection caused by the Plasmodium malariae parasite, one of several species that cause malaria. It is characterized by recurrent fever patterns and can lead to chronic infections if not treated. The condition typically presents with symptoms similar to other malaria types but may have distinct clinical features, such as quartan fever (fever spikes every 72 hours). While less severe than some other malaria species, it can still cause significant morbidity, especially in untreated or immunocompromised individuals.

Causes

The infection is caused by the Plasmodium malariae parasite, which is transmitted to humans through the bite of an infected Anopheles mosquito. The parasite enters the bloodstream and infects red blood cells, where it undergoes a life cycle that includes asexual replication and periodic release, leading to the characteristic fever patterns. Unlike some other malaria species, P. malariae can persist in the bloodstream for years, potentially causing asymptomatic or low-grade infections.

Risk Factors

• Residence in or travel to regions where Plasmodium malariae is endemic, such as parts of sub-Saharan Africa.
• Lack of preventive measures, such as insecticide-treated bed nets or antimalarial prophylaxis.
• Immunocompromised states, which may increase susceptibility to severe disease.
• Previous exposure to malaria, as partial immunity can develop but may wane over time.

Symptoms

• Recurrent fever with a 72-hour cycle (quartan fever), though this pattern may not always be present.
• Chills, sweats, and headache during fever episodes.
• Fatigue and malaise between fever spikes.
• In some cases, splenomegaly (enlarged spleen) or mild anemia.

Diagnosis

Diagnosis is confirmed by identifying the Plasmodium malariae parasite in a blood smear or through molecular testing (e.g., PCR). Microscopic examination of blood samples is the standard method, showing characteristic ring forms or band forms of the parasite. Clinical suspicion based on travel history, symptoms, and exposure is also critical for timely testing. Differentiation from other malaria species may require specialized laboratory techniques.

Treatment Options

Treatment typically involves antimalarial medications, such as chloroquine or primaquine, depending on regional resistance patterns and patient factors. The choice of drug is guided by local guidelines and the severity of infection. In uncomplicated cases, oral therapy is usually sufficient, while severe or complicated malaria may require intravenous medications and supportive care. Eradication of the parasite is essential to prevent relapse, as P. malariae can persist in the liver.

Prognosis and Follow-Up

With appropriate treatment, the prognosis for Plasmodium malariae malaria is generally good, though chronic low-level infections can occur. Follow-up may involve repeat blood tests to confirm parasite clearance, especially in cases with delayed treatment or atypical presentations. Patients should be monitored for recurrence of symptoms or complications, such as nephrotic syndrome, which is more commonly associated with this species.

Complications

• Nephrotic syndrome, a rare but serious complication involving kidney damage.
• Anemia due to prolonged or recurrent infection.
• Splenomegaly, which may persist even after treatment.
• In rare cases, severe disease in immunocompromised individuals.

Lifestyle & Prevention

• Use insecticide-treated bed nets when in endemic areas.
• Apply mosquito repellents and wear protective clothing.
• Take antimalarial prophylaxis as recommended for travel to high-risk regions.
• Seek prompt medical attention for fever after potential exposure to reduce severe outcomes.

When to Seek Professional Help

• Fever with a history of travel to malaria-endemic areas.
• Persistent or recurrent fever without an obvious cause.
• Symptoms of severe malaria, such as confusion, seizures, or difficulty breathing.
• Exposure to mosquitoes in regions where Plasmodium malariae is common, even if symptoms are mild.

Tips for Medical Coders

• Code B52 is specific to Plasmodium malariae malaria and should not be used for other malaria species.
• Documentation should specify the infecting species (Plasmodium malariae) to support accurate coding.
• Include details about the infection's severity, treatment, or complications if applicable, as these may impact coding for related conditions.
• Ensure the code is assigned only when the diagnosis is confirmed by laboratory testing or clinical criteria consistent with Plasmodium malariae infection.